Science Explorer Back to mapMap
Discussion
Hospital / health system · Pyatigorsk · Russia

Pyatigorsk Oncology Center

pmod.ruROR OpenAlex
Research works
14
▼ 16% vs 2018-21
Citations
172
12.5 per fractional work
Top-10% rate
5.4%
all institutions 10.0%
Open access
61%
world 40%
International
26%
world 18%
Pyatigorsk Oncology Center

Not ranked overall: Pyatigorsk Oncology Center is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pyatigorsk Oncology Center work in?

In all years, 43% of research at Pyatigorsk Oncology Center is in Health Sciences, 24% in Physical Sciences. Its largest fields are Medicine (39%), Social Sciences (14%), Engineering (10%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 43.2% of its workMedicine: 5 fractional works · 39.0% of its workObstetrics and Gynecology: 1 fractional works · 6.0% of its workOncology: 1 fractional works · 5.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 4.8% of its workPharmacology: 1 fractional works · 3.9% of its workSurgery: 1 fractional works · 3.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.2% of its workPathology and Forensic Medicine: 0 fractional works · 2.2% of its workAnatomy: 0 fractional works · 2.0% of its workDermatology: 0 fractional works · 1.8% of its workInfectious Diseases: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.2% of its workEpidemiology: 0 fractional works · 1.1% of its workHematology: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 3.0% of its workOral Surgery: 0 fractional works · 2.4% of its workGeneral Dentistry: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 1.2% of its workGeneral Health Professions: 0 fractional works · 1.2% of its workPhysical Sciences: 3 fractional works · 23.5% of its workEngineering: 1 fractional works · 10.3% of its workControl and Systems Engineering: 0 fractional works · 2.7% of its workMechanical Engineering: 0 fractional works · 2.4% of its workBiomedical Engineering: 0 fractional works · 1.9% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.7% of its workAutomotive Engineering: 0 fractional works · 1.2% of its workMechanics of Materials: 0 fractional works · 0.4% of its workChemistry: 1 fractional works · 10.0% of its workOrganic Chemistry: 1 fractional works · 6.4% of its workSpectroscopy: 0 fractional works · 2.4% of its workAnalytical Chemistry: 0 fractional works · 1.2% of its workComputer Science: 0 fractional works · 2.4% of its workInformation Systems: 0 fractional works · 2.0% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workGeology: 0 fractional works · 0.4% of its workEnvironmental Science: 0 fractional works · 0.4% of its workEnvironmental Chemistry: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 16.9% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 7.8% of its workGenetics: 0 fractional works · 3.5% of its workMolecular Biology: 0 fractional works · 2.9% of its workCancer Research: 0 fractional works · 1.4% of its workAgricultural and Biological Sciences: 1 fractional works · 4.9% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 2.0% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 1.0% of its workFood Science: 0 fractional works · 0.9% of its workAnimal Science and Zoology: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.5% of its workImmunology and Microbiology: 0 fractional works · 2.0% of its workImmunology: 0 fractional works · 1.7% of its workMicrobiology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.0% of its workPharmaceutical Science: 0 fractional works · 1.2% of its workPharmacology: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 16.4% of its workSocial Sciences: 2 fractional works · 13.5% of its workSociology and Political Science: 1 fractional works · 4.2% of its workPolitical Science and International Relations: 0 fractional works · 2.4% of its workSafety Research: 0 fractional works · 2.4% of its workDevelopment: 0 fractional works · 1.8% of its workEducation: 0 fractional works · 1.5% of its workLaw: 0 fractional works · 1.2% of its workBusiness, Management and Accounting: 0 fractional works · 1.8% of its workStrategy and Management: 0 fractional works · 1.2% of its workManagement of Technology and Innovation: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 0.4% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.4% of its workALL ITS WORKPyatigorskOncology Center14fractional works, all years
Life Sciences17%Physical Sciences24%Health Sciences43%Social Sciences16%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine539.0%
    2. Dentistry03.0%
    3. Health Professions01.2%
    1. Engineering110.3%
    2. Chemistry110.0%
    3. Computer Science02.4%
    4. Earth and Planetary Sciences00.4%
    5. Environmental Science00.4%
    1. Biochemistry, Genetics and Molecular Biology17.8%
    2. Agricultural and Biological Sciences14.9%
    3. Immunology and Microbiology02.0%
    4. Pharmacology, Toxicology and Pharmaceutics02.0%
    5. Neuroscience00.1%
    1. Social Sciences213.5%
    2. Business, Management and Accounting01.8%
    3. Economics, Econometrics and Finance00.6%
    4. Psychology00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.90× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.17× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.85× its world share, 0 worksImmunology and Micro…Neuroscience: 0.18× its world share, 0 worksNeuroscienceComputer Science: 0.91× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.77× its world share, 0 worksEarth and Planetary …Engineering: 1.42× its world share, 1 worksEngineeringEnvironmental Science: 0.24× its world share, 0 worksEnvironmental ScienceMedicine: 1.14× its world share, 1 worksMedicineBusiness, Management and Accounting: 0.56× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.84× its world share, 0 worksEconomics, Econometr…Psychology: 0.39× its world share, 0 worksPsychologySocial Sciences: 1.52× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.2×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology3.17×1 works
  2. Immunology and Microbiology1.85×0 works
  3. Social Sciences1.52×1 works
  4. Engineering1.42×1 works
  5. Medicine1.14×1 works
  6. Computer Science0.91×0 works
  7. Agricultural and Biological Sciences0.90×0 works
  8. Economics, Econometrics and Finance0.84×0 works
  9. Earth and Planetary Sciences0.77×0 works
  10. Business, Management and Accounting0.56×0 works
  11. Psychology0.39×0 works
  12. Environmental Science0.24×0 works
  13. Neuroscience0.18×0 works

Who are the top researchers at Pyatigorsk Oncology Center?

Ranked on the quality score, Vladimir Ivanovich Vladimirov lead among researchers whose main affiliation is Pyatigorsk Oncology Center.

  1. 1 Vladimir Ivanovich Vladimirov Russia · #287,398 worldwide 4.7k citations · 52 works
All ranked researchers at Pyatigorsk Oncology Center

What are the most cited papers from Pyatigorsk Oncology Center?

The most cited paper from Pyatigorsk Oncology Center is "Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study" (Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al., 2011), with 1,110 citations. Next come "A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407" (658) and "Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial" (100).

Most cited papers
#PaperReleasedCitations
1 Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Javier Cortés, Joyce O’Shaughnessy, David M. Loesch et al. · The Lancet Mar 2011 1,110
2 A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 Luis G Paz-Ares, David Vicente, Ali Reza Tafreshi et al. · Journal of Thoracic Oncology Open access 26 Jun 2020 658
3 Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial Mafalda Oliveira et al. · The Lancet Oncology 29 Oct 2024 100
4 Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study Gunnar Folprecht, Carles Pericay, Mark P. Saunders et al. · Annals of Oncology Open access 18 Apr 2016 85
5 Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer Michael Clemens, Oleg A. Gladkov, Elaina M. Gartner et al. · Breast Cancer Research and Treatment Open access 29 Dec 2014 80
All 93 most cited papers, with filters and sorting

Which research topics does Pyatigorsk Oncology Center publish most on?

By volume in 2022-now: Corruption and Economic Development, Advanced Control Systems Optimization, Human Resources and Workforce and Electrical Contact Performance and Analysis.

Corruption and Economic Development: 0 fractional worksAdvanced Control Systems Optimization: 0 fractional worksHuman Resources and Work…0Human Resources and Workforce: 0 fractional worksElectrical Contact Perfo…0Electrical Contact Performance and Analysis: 0 fractional worksElectric and Hybrid Vehi…0Electric and Hybrid Vehicle Technologies: 0 fractional worksMechanical and Thermal P…0Mechanical and Thermal Properties Analysis: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksAgricultural and Financial Auditing: 0 fractional worksKruppel-like factors research: 0 fractional works
Sociology and Political ScienceControl and Systems EngineeringSafety ResearchMechanical Engineering5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Corruption and Economic Development Sociology and Political Science 0 works
  2. 2 Advanced Control Systems Optimization Control and Systems Engineering 0 works
  3. 3 Human Resources and Workforce Safety Research 0 works
  4. 4 Electrical Contact Performance and Analysis Mechanical Engineering 0 works
  5. 5 Electric and Hybrid Vehicle Technologies Automotive Engineering 0 works
  6. 6 Mechanical and Thermal Properties Analysis Mechanical Engineering 0 works
  7. 7 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  8. 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  9. 9 Agricultural and Financial Auditing General Agricultural and Biological Sciences 0 works
  10. 10 Kruppel-like factors research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.6%not open39.4%

World: 40% of research is openly available.

with international co-authors25.8%domestic only74.2%

World: 18% is written across borders.

How has Pyatigorsk Oncology Center's research output changed?

Output in 2022-2025 was 16% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pyatigorsk Oncology Center as a percentage of every work published that year, 0.000018% in 2024.

still counting0.00010%0.00020%Pyatigorsk Oncology Center0.000037% in 202519801990200020102020

Fractional works of Pyatigorsk Oncology Center over all fractional works that year. How the balance of science has shifted.

Other research institutions in Pyatigorsk

All research institutions in Pyatigorsk

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pyatigorsk Oncology Center. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.